| Business Summary | | Forbes
Medi-Tech
Inc.
is
a
diversified
health
sciences
company
dedicated
to
the
research,
development
and
commercialization
of
innovative
nutraceutical
and
pharmaceutical
products
derived
from
nature.
By
extracting
plant
sterols
from
pulping
by-products,
Forbes
is
developing
cholesterol-lowering
agents
to
be
used
both
as
functional
food
ingredients
and
pharmaceutical
therapeutics
against
heart
disease.
Forbes
is
also
developing
fermentation
technology
that
converts
plant
sterols
into
pharmaceutical
fine
chemicals,
essential
in
the
production
of
various
pharmaceutical
steroids,
such
as
contraceptive
agents
and
anti-inflammatories. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Forbes
Medi-Tech
Inc.
is
a
health
sciences
company
dedicated
to
the
research,
development
and
commercialization
of
nutraceutical
and
pharmaceutical
products
derived
from
nature,
currently
developing
cholesterol-lowering
agents.
For
the
nine
months
ended
4/30/01,
total
revenue
totaled
C$4.4
million,
up
from
C$1.8
million.
Net
loss
totaled
C$17.1
million,
up
from
C$7.8
million.
Results
reflect
initial
product
sales,
offset
by
increased
R&D
expenses
and
a
C$2.7
million
write-down. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Tazdin Esmail | Chairman,
CEO | Charles Butt | Pres,
Director | Don MacDonald | CFO,
Sr. VP | Jack Miller | Exec.
VP, Director | Egon Novak, M.D., Ph.D. | Sr.
VP - Discovery, Director |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|